2020
DOI: 10.1016/j.meegid.2020.104567
|View full text |Cite
|
Sign up to set email alerts
|

Methicillin-resistant Staphylococcus aureus bacteraemia, 2003–2015: Comparative evaluation of changing trends in molecular epidemiology and clinical outcomes of infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 20 publications
0
4
0
1
Order By: Relevance
“…After reviewing the full texts, we excluded other studies according to the eligibility criteria. Twenty studies (4,5,(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27) were included in the final analysis. The process of article selection is shown in Figure 1.…”
Section: Results Of Study Inclusionmentioning
confidence: 99%
“…After reviewing the full texts, we excluded other studies according to the eligibility criteria. Twenty studies (4,5,(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27) were included in the final analysis. The process of article selection is shown in Figure 1.…”
Section: Results Of Study Inclusionmentioning
confidence: 99%
“…In our study, the mortality rate due to MRSA bacteremia was 17%. The risk factors for mortality in MRSA bacteremia are age, catheter device use, and exposure to macrolides [25][26][27]. Our study showed that those who died were older than those alive.…”
Section: Plos Onementioning
confidence: 61%
“…Early removal of devices in MRSA bacteremia is important because MRSA forms biofilms, which reduce the effectiveness of antimicrobial agents [37,38]. In addition, catheter-related bacteremia is strongly associated with in-hospital mortality [27].…”
Section: Plos Onementioning
confidence: 99%
“…Staphylococcus aureus resistentes a meticilina (MRSA) son los patógenos predominantes causantes de infecciones invasivas tales como las bacteriemias (Niek et al, 2020). Con datos obtenidos en 2018, en-viados al Centro Europeo de Vigilancia de la Resistencia Antimicrobiana (EARS-Net), provenientes de 30 países de la Unión Europea y de la Comunidad Económica Europea, el porcentaje de MRSA ha venido a la baja, sin embargo, los niveles en Europa siguen siendo muy elevados en algunos países; oscilando entre el 1,0% en Noruega y el 44,4% en Rumanía, con una media ponderada por población del 16,9% (ECDC, 2018).…”
Section: Impacto De Las Infecciones Por Staphylococcus Aureus Multidr...unclassified